Search Results

There are 7061 results for: content related to: Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants

  1. Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans

    The Journal of Clinical Pharmacology

    Volume 50, Issue 2, February 2010, Pages: 126–142, Dr Nagy A. Farid, Dr Atsushi Kurihara and Dr Steven A. Wrighton

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009343005

  2. You have free access to this content
    Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 8, August 2010, Pages: 1678–1684, M. J. SORICH, A. VITRY, M. B. WARD, J. D. HOROWITZ and R. A. MCKINNON

    Version of Record online : 21 MAY 2010, DOI: 10.1111/j.1538-7836.2010.03923.x

  3. Pharmacokinetics and Pharmacodynamics of Prasugrel, a Thienopyridine P2Y12 Inhibitor

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 9, September 2009, Pages: 1089–1102, Dr. Paul P. Dobesh

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.9.1089

  4. You have full text access to this OnlineOpen article
    TRITON and Beyond: New Insights into the Profile of Prasugrel

    Cardiovascular Therapeutics

    Volume 30, Issue 4, August 2012, Pages: e174–e182, Joseph A. Jakubowski, Jeffrey S. Riesmeyer, Sandra L. Close, Amy G. Leishman and David Erlinge

    Version of Record online : 17 FEB 2011, DOI: 10.1111/j.1755-5922.2011.00263.x

  5. Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel

    The Journal of Clinical Pharmacology

    Volume 48, Issue 4, April 2008, Pages: 475–484, Dr David S. Small, Dr Nagy A. Farid, Mr Christopher D. Payne, Dr Govinda J. Weerakkody, Ms Ying G. Li, Dr John T. Brandt, Dr Daniel E. Salazar and Dr Kenneth J. Winters

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008315310

  6. Integrated Analysis of Pharmacokinetic Data Across Multiple Clinical Pharmacology Studies of Prasugrel, a New Thienopyridine Antiplatelet Agent

    The Journal of Clinical Pharmacology

    Volume 51, Issue 3, March 2011, Pages: 321–332, Dr David S. Small, Ms Ying G. Li, Mr C. Steven Ernest II, Mr John H. April, Dr Nagy A. Farid, Mr Christopher D. Payne, Dr Kenneth J. Winters, Dr Shashank Rohatagi and Dr Lan Ni

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010367429

  7. Prasugrel, a New Platelet Inhibitor

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 77, Issue 3, May/June 2010, Pages: 315–323, Debbie Yee, Joanne Meyer, Gina Caliendo and Veronica Oviedo

    Version of Record online : 20 MAY 2010, DOI: 10.1002/msj.20185

  8. Prasugrel: A Critical Comparison with Clopidogrel

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 12, December 2009, Pages: 1441–1451, Dr. Kurt M. Reinhart, Dr. C. Michael White and Dr. William L. Baker

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.12.1441

  9. You have free access to this content
    Clinical implications of drug–drug interactions with P2Y12 receptor inhibitors

    Journal of Thrombosis and Haemostasis

    Volume 12, Issue 1, January 2014, Pages: 2–13, J. M. Siller-Matula, D. Trenk, S. Krähenbühl, A. D. Michelson and G. Delle-Karth

    Version of Record online : 9 JAN 2014, DOI: 10.1111/jth.12445

  10. A Risk–Benefit Assessment of Prasugrel, Clopidogrel, and Genotype-Guided Therapy in Patients Undergoing Percutaneous Coronary Intervention

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 5, May 2012, Pages: 829–837, G F Guzauskas, D A Hughes, S M Bradley and D L Veenstra

    Version of Record online : 28 MAR 2012, DOI: 10.1038/clpt.2011.303

  11. Prasugrel vs. clopidogrel in acute coronary syndrome patients treated with prasugrel

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 6, December 2014, Pages: 663–672, W. H. Olson, Y.-W. Ma, F. Laliberté, P. Lefebvre, C. Crivera, J. R. Schein, L. E. Fields, K. Dea, G. Germain and S. M. Lynch

    Version of Record online : 23 SEP 2014, DOI: 10.1111/jcpt.12209

  12. You have free access to this content
    Effect of grapefruit juice on the bioactivation of prasugrel

    British Journal of Clinical Pharmacology

    Volume 80, Issue 1, July 2015, Pages: 139–145, Mikko T. Holmberg, Aleksi Tornio, Hanna Hyvärinen, Mikko Neuvonen, Pertti J. Neuvonen, Janne T. Backman and Mikko Niemi

    Version of Record online : 1 JUN 2015, DOI: 10.1111/bcp.12581

  13. You have free access to this content
    Genetic testing in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cost-effectiveness analysis

    Journal of Thrombosis and Haemostasis

    Volume 11, Issue 1, January 2013, Pages: 81–91, A. LALA, J. S. BERGER, G. SHARMA, J. S. HOCHMAN, R. SCOTT BRAITHWAITE and J. A. LADAPO

    Version of Record online : 27 JAN 2013, DOI: 10.1111/jth.12059

  14. Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 12, December 2008, Pages: 1483–1493, Dr. Nagy A. Farid, Dr. David S. Small, Mr. Christopher D. Payne, Dr. Joseph A. Jakubowski, Dr. John T. Brandt, Ms. Ying G. Li, Mr. C. Steven Ernest II, Dr. Daniel E. Salazar, Dr. Christopher S. Konkoy and Dr. Kenneth J. Winters

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.12.1483

  15. Prasugrel – ein neuer ADP-Rezeptor-Antagonist. Prodrug-Aktivierung als entscheidender Unterschied

    Pharmazie in unserer Zeit

    Volume 38, Issue 4, Juli 2009, Pages: 320–328, Susanne Alban

    Version of Record online : 1 JUL 2009, DOI: 10.1002/pauz.200900321

  16. Prasugrel: A Novel P2Y12 Receptor Inhibitor

    Pharmacology in the Catheterization Laboratory

    Itsik Ben-Dor, Mickey Scheinowitz, Ron Waksman, Pages: 59–66, 2009

    Published Online : 30 OCT 2009, DOI: 10.1002/9781444306347.ch9

  17. Prevalence of CYP2C19 alleles, pharmacokinetic and pharmacodynamic variation of clopidogrel and prasugrel in Bangladeshi population

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 5, May 2015, Pages: 451–457, Muhammad Shahdaat Bin Sayeed, Mohd Nazmul Hasan Apu, Maliha Tabassum Munir, Maizbha Uddin Ahmed, Mohammad Safiqul Islam, M Maksumul Haq, Chowdhury H Ahsan, M A Rashid, Jae Gook Shin and Abul Hasnat

    Version of Record online : 23 APR 2015, DOI: 10.1111/1440-1681.12390

  18. You have free access to this content
    Genetics of platelet inhibitor treatment

    British Journal of Clinical Pharmacology

    Volume 77, Issue 4, April 2014, Pages: 642–653, Dietmar Trenk and Willibald Hochholzer

    Version of Record online : 20 MAR 2014, DOI: 10.1111/bcp.12230

  19. You have full text access to this OnlineOpen article
    The Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Japanese Volunteers

    Clinical Pharmacology in Drug Development

    Volume 5, Issue 6, November/December 2016, Pages: 480–487, Kazuo Umemura and Takayuki Iwaki

    Version of Record online : 25 APR 2016, DOI: 10.1002/cpdd.259

  20. You have free access to this content
    Pharmacokinetic basis of the antiplatelet action of prasugrel

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 1, February 2012, Pages: 39–46, Karsten Schrör, Jolanta M. Siller-Matula and Kurt Huber

    Version of Record online : 5 SEP 2011, DOI: 10.1111/j.1472-8206.2011.00986.x